We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Consolidation of Drug Import Oversight Aimed at Harmonizing U.S. Port Policies
Consolidation of Drug Import Oversight Aimed at Harmonizing U.S. Port Policies
The FDA plans to consolidate its 16 districts overseeing pharmaceutical imports into just four or five under a reorganization plan designed to make inspection policies and procedures more uniform across all ports of entry.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor